Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

48.65
Delayed Data
As of Sep 19
 -0.02 / -0.04%
Today’s Change
30.89
Today|||52-Week Range
48.88
+35.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Operating ActivitiesNet Income / Starting Line1.5B1.2B1.5B1.5B
 
 
 
 
 
Depreciation110.6M143.8M102.0M129.2M
 
 
 
 
 
Total Other Cash Flow1.1B231.7M192.7M136.1M
 
 
 
 
 
Funds From Operations2.6B1.6B1.8B1.8B
 
 
 
 
 
Funds From/For Other Operating Expenses359.8M23.1M13.0M234.7M
 
 
 
 
 
Net Cash Flow - Operating Activities2.3B1.6B1.7B1.5B
 
 
 
 
 
 
InvestingIncrease In Investments-15.0M15.6M0.00-5.9M
 
 
 
 
Decrease In Investments4.3M-127.7K144.9M152.0M
 
 
 
 
 
Capital Expenditures-268.1M-365.1M-231.0M-233.9M
 
 
 
 
 
Fixed Asset Disposal150.0K738.5K----
 
 
 
Other Investing - Uses0.00-16.6M0.000.00
 
 
Other Investing - Sources0.003.4M0.000.00
 
 
Net Cash Flow Investing-401.3M-399.0M-101.7M-108.9M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed-541.0M-591.4M-611.4M-566.8M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-1.1B34.3M-1.6B-36.1M
 
 
 
 
 
Other Sources - Financing0.000.00283.5M-283.5M
 
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-1.7B-557.1M-2.0B-886.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash1.0M8.0M1.2M-25.0M
 
 
 
 
 
 
Net Change In Cash195.7M644.0M-334.0M532.0M